[1] Ito Y,Goldschmeding R,Bende R,et al. Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis. J Am Soc Nephrol,2001,12(3):472-484. [2] Paradis V,Dargere D,Bonvust F,et al. Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab Invest,2002,82(6):767-774. [3] Paradis V,Dargere D,Vidaud M,et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology,1999,30(4):968-976. [4] Abou-Shady M,Friess H. Connective tissue growth factor in human liver cirrhosis. Liver,2000,20(4):296-304. [5] Shiratori Y,Geerts A,Ichida T,et al. Kupffer cells from CCl4-induced fibrotic livers stimulate proliferation of fat-storing cells. J Hepatol,1986,3(3):294-303. [6] 汪美凤,平键,成扬. 肝星状细胞主要信号通路与肝纤维化的关系. 实用肝脏病杂志,2012,13(6):466-469. [7] 彭梅娟,郝春秋,白雪帆,等.介导大鼠结缔组织生长因子基因沉默的慢病毒载体转移质粒的构建及鉴定. 生物技术通讯,2008,19(3):350-352. [8] Tong Z,Chen R,Alt DS,et al. Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes. Hepatology,2009,50(3):939-947. [9] Kothapalli D,Grotendorst GR. CTGF modulates cell cycle progression in cAMP-arrested NRK fibroblasts. J Cell Physiol, 2000,182(1):119-126. [10] Furlong F,Crena J,Thornton L,et al. Dysregulated intracellular signaling impairs CTGF-stimulated responses in human mesangial cells exposed to high extracellular glucose. Am J Physiol Renal Physiol,2007,292(6):F1691-1700. [11] Hishikawa K,Oemar BS,Tanner FC,et al. Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem,1999,274(52):37461-37466. [12] Croci S,Landuzzi L,Astolfa A,et al. Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells. Cancer Res,2004,64(5):1730-1736. [13] 李菊英,苟笑丹,赵刚,等. 胃癌组织中CTGF蛋白表达与细胞凋亡的相关性. 青海医学院学报,2010,31(3):160-165. [14] 吴惠春,张斌. 肝星状细胞与抗肝纤维化治疗的研究进展.实用肝脏病杂志,2012,15(2):172-173. [15] Higashiyama H,Yoshimoto D,Kaise T,et al. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis. Exp Mol Pathol,2007,83(1):39-46. [16] Gressner OA,Gressner AM. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int, 2008, 28(8):1065-1079. |